
Sign up to save your podcasts
Or
This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.
See omnystudio.com/listener for privacy information.
5
33 ratings
This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.
See omnystudio.com/listener for privacy information.
23 Listeners
55 Listeners
19 Listeners
65 Listeners
41 Listeners
84 Listeners
18 Listeners
19 Listeners
276 Listeners
20 Listeners
15 Listeners
13 Listeners
70 Listeners
24 Listeners
10 Listeners